Overall, these data suggest that SMYD3 orchestrates epigenetic, metabolic, and proliferative events in the adaptive response of tumor cells during carcinogenesis and cancer progression, acting as a crucial modulator of major oncogenic processes, such as epigenetic regulation, DNA processing, and cancer-related signaling (Fig. 5). Here, SMYD3 is linked to cancer.